PubRank

T Hovi

Author PubWeight™ 184.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis 1980 4.10
2 Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986 3.14
3 Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J Virol 1995 2.66
4 Fibronectin is produced by human macrophages. J Exp Med 1980 2.44
5 Genetic and phylogenetic clustering of enteroviruses. J Gen Virol 1996 2.31
6 Classification of enteroviruses based on molecular and biological properties. J Gen Virol 1997 2.16
7 Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology 1994 2.13
8 A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 1995 2.08
9 Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 1994 1.96
10 Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl Environ Microbiol 1988 1.94
11 RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol 1991 1.91
12 Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol 1995 1.83
13 Infections, inflammation, and the risk of coronary heart disease. Circulation 2000 1.77
14 Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol 1987 1.76
15 Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004 1.71
16 Cultured human monocytes synthesize and secrete alpha2-macroglobulin. J Exp Med 1977 1.70
17 Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1997 1.62
18 Rotavirus infections in adults in association with acute gastroenteritis. J Med Virol 1978 1.61
19 Rapid detection of human rhinoviruses in nasopharyngeal aspirates by a microwell reverse transcription-PCR-hybridization assay. J Clin Microbiol 1999 1.52
20 Enzyme immunoassay, complement fixation and hemagglutination inhibition tests in the diagnosis of influenza A and B virus infections. Purified hemagglutinin in subtype-specific diagnosis. J Virol Methods 1985 1.46
21 Respiratory coronavirus infections in children younger than two years of age. Pediatr Infect Dis J 2000 1.44
22 Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign. Neurology 1989 1.41
23 Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol 1976 1.41
24 The role of de novo purine synthesis in lymphocyte transformation. Ciba Found Symp 1977 1.37
25 Stimulation of density-inhibited cell cultures by insulin. J Cell Physiol 1973 1.37
26 Outbreak of poliomyelitis in Finland in 1984. Description of nine cases with persisting paralysis. Scand J Infect Dis 1986 1.34
27 Suppression of the formation of polyamines and macromolecules by DL-alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in phytohaemagglutinin-activated human lymphocytes. Biochem J 1979 1.32
28 Determination of mumps and influenza antibodies by haemolysis-in-gel. Arch Virol 1976 1.29
29 Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine. J Virol 1987 1.29
30 Rotavirus associated with acute gastroenteritis in adults. Lancet 1976 1.28
31 Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J 2001 1.25
32 Structural proteins and subunits of rubella virus. J Virol 1972 1.25
33 An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution. Virology 1993 1.24
34 Molecular epidemiology of echovirus 30 in Europe: succession of dominant sublineages within a single major genotype. Arch Virol 2001 1.23
35 Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J Gen Virol 1990 1.20
36 Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis 1998 1.20
37 Detection of poliovirus antigen by enzyme immunoassay. J Clin Microbiol 1986 1.19
38 Proliferation of human peripheral blood lymphocytes induced by A23187, a streptomyces antibiotic. Exp Cell Res 1976 1.19
39 Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Lancet 1975 1.18
40 Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 1999 1.18
41 Clinical signs and laboratory tests in the differential diagnosis of arthritis in children. Am J Dis Child 1987 1.17
42 Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged. J Clin Immunol 1988 1.17
43 Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique. Virology 1991 1.17
44 Genetic variation in vivo and proposed functional domains of the 5' noncoding region of poliovirus RNA. J Virol 1992 1.17
45 Cleavage of VP1 and modification of antigenic site 1 of type 2 polioviruses by intestinal trypsin. J Virol 1988 1.16
46 Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J Gen Virol 1987 1.14
47 Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol 1985 1.14
48 Antigenic and molecular characterization of wild type 1 poliovirus causing outbreaks of poliomyelitis in Albania and neighboring countries in 1996. J Clin Microbiol 1998 1.14
49 Disodium cromoglycate can inhibit virus-induced cytopathic effects in vitro. Br Med J 1977 1.13
50 Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005 1.13
51 Viral water contamination as the cause of aseptic meningitis outbreak in Belarus. Cent Eur J Public Health 2001 1.12
52 Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 1998 1.10
53 Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000 1.09
54 Increased secretion of plasminogen activator by human macrophages after exposure to leukocyte interferon. FEBS Lett 1981 1.08
55 Antigenic and molecular properties of type 3 poliovirus responsible for an outbreak of poliomyelitis in a vaccinated population. J Gen Virol 1986 1.08
56 Rapid diagnosis of respiratory adenovirus infections in young adult men. J Clin Microbiol 1986 1.08
57 Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J Infect Dis 1997 1.07
58 Monocyte is the main producer of human leukocyte alpha interferons following Sendai virus induction. Prog Med Virol 1984 1.06
59 Human macrophages synthesize and secrete a major 95,000-dalton gelatin-binding protein distinct from fibronectin. J Biol Chem 1982 1.05
60 Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Euro Surveill 2010 1.05
61 A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol 1999 1.05
62 Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak. J Gen Virol 1988 1.04
63 Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes. J Gen Virol 2000 1.04
64 Coronavirus infections of man associated with diseases other than the common cold. J Med Virol 1980 1.04
65 Reorganization of cytoskeletal and contractile elements during transition of human monocytes into adherent macrophages. Lab Invest 1982 1.04
66 Diagnosis of poliomyelitis by demonstration of intrathecal synthesis of neutralizing antibodies. J Infect Dis 1986 1.04
67 Serological diagnosis of influenza A and B infections by enzyme immunoassay. Comparison with the complement fixation test. J Virol Methods 1984 1.02
68 OC43 strain-related coronavirus antibodies in different age groups. J Med Virol 1979 1.01
69 Infectivity and some physicochemical characteristics of rubella virus ribonucleic acid. Virology 1970 1.01
70 Etiological diagnosis of pneumonia in military conscripts by combined use of bacterial culture and serological methods. Eur J Clin Microbiol Infect Dis 1988 1.00
71 Poliovirus-specific intestinal antibody responses coincide with decline of poliovirus excretion. J Infect Dis 2000 1.00
72 Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study. Acta Derm Venereol 1985 1.00
73 Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 2002 0.99
74 Virological and serological analysis of rhinovirus infections during the first two years of life in a cohort of children. J Med Virol 2002 0.98
75 Generation of virus genetic lineages during an outbreak of poliomyelitis. J Gen Virol 1991 0.98
76 No measles in Finland. Lancet 1997 0.97
77 Neonatal Type I diabetes associated with maternal echovirus 6 infection: a case report. Diabetologia 2000 0.97
78 Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella. J Med Virol 1985 0.97
79 Purification of rubella virus particles. J Gen Virol 1969 0.97
80 Restricted replication of herpes simplex virus in human monocyte cultures: role of interferon. Virology 1983 0.96
81 Age-specific prevalence of complement-fixing antibodies to sixteen viral antigens: a computer analysis of 58,500 patients covering a period of eight years. J Med Virol 1984 0.96
82 Solid-phase enzyme immunoassay for rotavirus antigen: faecal protease activity as a reason for false-negative results. J Virol Methods 1982 0.96
83 Relationships between simian and human enteroviruses. J Gen Virol 1999 0.96
84 The effect of air ionization on the air-borne transmission of experimental Newcastle disease virus infections in chickens. J Hyg (Lond) 1979 0.95
85 Prophylactic oral acyclovir after renal transplantation. Transplantation 1985 0.95
86 Pathogenic bacteria and viruses in induced sputum or pharyngeal secretions of adults with stable asthma. Thorax 2006 0.95
87 Intrathecal immune response and virus-specific immunoglobulin M antibodies in laboratory diagnosis of acute poliomyelitis. J Clin Microbiol 1993 0.95
88 Poliovirus surveillance by examining sewage water specimens: studies on detection probability using simulation models. Risk Anal 2001 0.94
89 Genetic diversity and rapid evolution of poliovirus in human hosts. Curr Top Microbiol Immunol 1992 0.94
90 Virus excretion and strain specific antibody responses after oral poliovaccine in previously immunised children. J Med Virol 1987 0.93
91 Rapid increase of phosphoribosyl pyrophosphate concentration after mitogenic stimulation of lymphocytes. FEBS Lett 1975 0.93
92 Simian virus 40 (SV40)-like DNA sequences not detectable in finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol Carcinog 1999 0.93
93 Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 1982 0.92
94 Isolation of vaccine-derived polioviruses in the Slovak Republic. Eur J Clin Microbiol Infect Dis 2005 0.92
95 Protection of man from natural infection with influenza A2 Hong Kong virus by amantadine: a controlled field trial. Br Med J 1970 0.91
96 Antigenic modification of polioviruses by host proteolytic enzymes. Arch Virol 1990 0.90
97 Rubella virus-specific ribonucleic acids in infected BHK21 cells. J Gen Virol 1970 0.90
98 Stimulation of chicken lymphocytes by T- and B-cell mitogens. Cell Immunol 1978 0.90
99 Efficient RGD-independent entry process of coxsackievirus A9. Arch Virol 1996 0.90
100 Type 3 poliovirus/Finland/1984 is genetically related to common Mediterranean strains. J Gen Virol 1990 0.89
101 Modified base compositions at degenerate positions of a mutagenic oligonucleotide enhance randomness in site-saturation mutagenesis. Nucleic Acids Res 1998 0.89
102 Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections. Clin Exp Immunol 1985 0.89
103 Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood. Pediatr Infect Dis J 1988 0.87
104 Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 2002 0.87
105 Detection of rotavirus in faecal specimens by enzyme immunoassay, latex agglutination and electron microscopy. Scand J Infect Dis 1985 0.87
106 Induction of neutralizing antibodies by synthetic peptides representing the C terminus of coxsackievirus A9 capsid protein VP1. J Gen Virol 1998 0.87
107 Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 1998 0.87
108 Localized outbreak of enteroviral meningitis in adults. Acta Neurol Scand 1987 0.86
109 Several inhibitors of ornithine and adenosylmethionine decarboxylases may also have antiproliferative effects unrelated to polyamine depletion. Biochim Biophys Acta 1981 0.86
110 Variability in the integrity of human enteroviruses exposed to various simulated in vivo environments. Microb Pathog 1998 0.85
111 Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996 0.85
112 Response of enzymes involved in the metabolism of polyamines to phytohaemagglutinin-induced activation of human lymphocytes. Biochem J 1981 0.85
113 Enterovirus, mycoplasma and other infections as predictors for myocardial infarction. J Intern Med 2002 0.84
114 Genetic divergence of poliovirus strains isolated in the Karachi region of Pakistan. J Gen Virol 1995 0.84
115 Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination. J Clin Immunol 1987 0.84
116 Induction of interferon-alpha in human leukocytes by polioviruses: wild-type strains are better inducers than attenuated strains. Virology 1988 0.84
117 A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Bone Marrow Transplant 2007 0.83
118 Partial RNA sequencing of eight supposed derivatives of type 3 poliovirus/USA/Saukett/50 reveals remarkable differences between three apparent substrains. Virology 1989 0.83
119 Improved distribution of antigenic site specificity of poliovirus-neutralizing antibodies induced by a protease-cleaved immunogen in mice. J Virol 1990 0.82
120 Association between cerebral infarction and increased serum bacterial antibody levels in young adults. Acta Neurol Scand 1986 0.82
121 Polyamine depletion results in impairment of polyribosome formation and protein synthesis before onset of DNA synthesis in mitogen-activated human lymphocytes. Eur J Biochem 1985 0.82
122 Induction of interferon in human leukocyte cultures by natural pathogenic respiratory viruses. J Interferon Res 1993 0.82
123 Immunoglobulin class-specific serological responses to adenovirus in respiratory infections of young adult men. J Clin Microbiol 1986 0.81
124 Cyclic AMP and cyclic GMP enhance growth of chick embryo fibroblasts. Nat New Biol 1973 0.81
125 Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997 0.81
126 A population-based prospective survey of newborn infants with suspected systemic infection: occurrence of sporadic enterovirus and adenovirus infections. J Clin Virol 1999 0.81
127 Herpes simplex virus infection in human monocyte cultures: dose-dependent inhibition of monocyte differentiation resulting in abortive infection. J Gen Virol 1981 0.81
128 Site-saturation mutagenesis of the PALTAVETG motif in coxsackievirus A9 capsid protein VP1 reveals evidence of conservation of a periodic hydrophobicity profile. J Gen Virol 1999 0.80
129 Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivity. J Virol 2001 0.80
130 Replication of poliovirus in human mononuclear phagocyte cell lines is dependent on the stage of cell differentiation. J Med Virol 1989 0.80
131 Persistence and class-specificity of neutralizing antibody response induced by trypsin-cleaved type 3 poliovirus in mice. Vaccine 1993 0.80
132 Picornavirus proteins share antigenic determinants with heat shock proteins 60/65. J Med Virol 2000 0.80
133 Polypeptide composition of human macrophage gelatinase. Acta Chem Scand B 1987 0.80
134 Virus-induced interferon production in human leukocytes: a low responder to one virus can be a high responder to another virus. J Interferon Res 1991 0.79
135 Release of rubella virus ribonucleic acid from ribonucleoprotein by polyanions. J Virol 1972 0.79
136 Randomised, controlled trial with the trypsin-modified inactivated poliovirus vaccine: assessment of intestinal immunity with live challenge virus. Vaccine 1999 0.79
137 Nonspecific inhibitors of coronavirus OC43 haemagglutination in human sera. Med Microbiol Immunol 1978 0.79
138 Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia. Ann Intern Med 1990 0.79
139 Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome. Clin Infect Dis 1994 0.79
140 Purine reutilization in phytohemagglutinin-stimulated human T-lymphocytes. Exp Cell Res 1978 0.79
141 Growth control in chick embryo fibroblasts; no evidence for a specific role for cyclic purine nucleotides. Cell 1974 0.79
142 Purine metabolism and control of cell proliferation. Ciba Found Symp 1977 0.79
143 Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine. J Med Virol 2001 0.78
144 Effect of concomitant food intake on absorption kinetics of erythromycin in healthy volunteers. Eur J Clin Pharmacol 1985 0.78
145 Sensitive interferon assay based on immunoenzymatic quantification of viral antigen synthesis. J Virol Methods 1982 0.78
146 Screening enteroviruses for beta-cell tropism using foetal porcine beta-cells. J Gen Virol 2001 0.78
147 Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome. Am J Epidemiol 1998 0.78
148 Twenty-one patients with strictly defined postpoliomyelitis syndrome: no poliovirus-specific IgM antibodies in the cerebrospinal fluid. Ann Neurol 1994 0.78
149 Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins. Virology 1994 0.78
150 Selective cleavage by trypsin of the capsid protein VP1 of type 3 poliovirus results in improved sorting of cell bound virions. Arch Virol 1996 0.78
151 Congenital malformations and oral poliovirus vaccination during pregnancy. Lancet 1989 0.77
152 Restricted variability of a 17 nucleotide stretch within the 5'-noncoding region of poliovirus genome. Epidemiol Infect 1989 0.77
153 Immunogenicity of a pilot inactivated poliovirus vaccine with trypsin-treated type 3-component. Vaccine 1997 0.77
154 Antibodies to human coronavirus OC43 measured by radial haemolysis in gel. Scand J Infect Dis 1977 0.77
155 The Mr 95,000 gelatin-binding protein in differentiated human macrophages and granulocytes. Blood 1985 0.77
156 Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J Med Virol 2003 0.77
157 Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children. J Clin Virol 1999 0.77
158 Interferon production by leukocytes in children with otitis media with effusion. Int J Pediatr Otorhinolaryngol 1996 0.77
159 Divalent cation ionophore A23187 forms lipid soluble complexes with leucine and other amino acids. Nature 1975 0.77
160 Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination. J Pediatr 2001 0.77
161 Genetic and phenotypic diversity of echovirus 30 strains and pathogenesis of type 1 diabetes. J Med Virol 2007 0.77
162 Problems with biotin-labelled virions as probes in poliovirus-specific mu-capture-IgM assays. J Clin Virol 1999 0.76
163 Good seroresponse to enhanced-potency inactivated poliovirus vaccine in patients on chronic dialysis. Nephrol Dial Transplant 1990 0.76
164 Antipolio prophylaxis of immunocompromised children during a nationwide oral poliovaccine campaign. Pediatr Infect Dis J 1987 0.76
165 Interferon affects the formation of adhesion plaques in human monocyte cultures. Exp Cell Res 1985 0.76
166 Reversible release of chick embryo fibroblast cultures from density dependent inhibition of growth. J Cell Physiol 1975 0.76
167 Variation in liposome binding among enteroviruses. Virology 2001 0.76
168 Deficiency in interferon production by leukocytes from children with recurrent respiratory infections. Clin Diagn Virol 1993 0.76
169 Respiratory viruses in acute otitis media. N Engl J Med 1999 0.75
170 Carditis associated with coronavirus infection. Lancet 1980 0.75
171 CCR5 deficiency and severe polio infection in the 1984 outbreak in Finland. J Med Virol 2013 0.75
172 [What should be on the list of elimination after polio virus?]. Duodecim 2000 0.75
173 Expression of Coxsackievirus B4 proteins VP0 and 2C in Escherichia coli and generation of virus protein recognizing antisera. J Virol Methods 1997 0.75
174 Impaired interferon production by leukocytes from patients with Bell palsy and lack of findings suggestive for a systemic viral involvement. Am J Otol 1997 0.75
175 Inhibition of phytohemagglutinin-induced DNA synthesis and of adenosine deamination by 5-azacytidine and 5-aza-2'-deoxycytidine in intact human cells. Neoplasma 1985 0.75
176 Mitogen-induced T-lymphocyte proliferation: a reappraisal of the early requirement of extracellular ionized calcium. Biochem Biophys Res Commun 1979 0.75
177 Virus-induced interferon production in leukocyte cultures from children with recurrent respiratory infections. A follow-up study. Clin Diagn Virol 1996 0.75
178 Transformation-associated increase of phosphoribosyl pyrophosphate concentration in chick embryo fibroblasts. FEBS Lett 1979 0.75
179 Rapid laboratory diagnosis of European virus diseases. Med Biol 1977 0.75
180 Improved sensitivity of restriction endonuclease analysis of herpes simplex virus type 2 DNA with polyacrylamide gradient gel electrophoresis. J Virol Methods 1987 0.75
181 Adenine and adenosine metabolism in phytohemagglutinin (PHA) - stimulated and unstimulated normal human lymphocytes. Adv Exp Med Biol 1977 0.75
182 [Is the eradication of polio successful in Finland and elsewhere?]. Duodecim 2001 0.75
183 [Hepatitis A vaccine is available]. Duodecim 1993 0.75
184 Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets. Eur J Clin Pharmacol 1983 0.75
185 Lack of protection from rotavirus infection in children with congenital intestinal lactase deficiency. J Infect Dis 1983 0.75
186 Nuclear war against herpesviruses. Med Biol 1980 0.75
187 [Receptors for viruses]. Duodecim 1997 0.75
188 Immunization against poliomyelitis: still problems to solve in both developed and developing countries. Ann Clin Res 1986 0.75
189 [New drugs against herpesviruses]. Duodecim 1980 0.75
190 Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations. Am J Epidemiol 1993 0.75
191 Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum (roseola infantum). Pediatrics 1992 0.75
192 [Changes in poliovirus antigenicity and their practical effects on vaccination]. Duodecim 1988 0.75
193 Drug-resistant herpesvirus mutants -- tough or bluff? Med Biol 1982 0.75
194 Outbreak of poliomyelitis in Finland: no distinct HLA association. Tissue Antigens 1986 0.75
195 [Hepatitis B: prevention]. Suom Hammaslaakarilehti 1991 0.75
196 Absorption of penicillin V from mixture formulations. Comparison of potassium and benzathine salts. J Int Med Res 1981 0.75
197 Age-specific prevalence of antibodies to pyrimidine kinase enzymes of herpes simplex virus types 1 and 2, and of varicella zoster virus. J Med Virol 1986 0.75
198 [Problems in the management of drug-resistant herpesvirus infections]. Duodecim 1989 0.75
199 Adamantine influenza and the adamantanes. Med Biol 1981 0.75
200 Genomic variation of herpes simplex virus type 2 isolates analysed by hybridization after electroblotting from polyacrylamide gels. Mol Cell Probes 1990 0.75
201 Bacteriology of odontogenic apical periodontitis and effect of penicillin treatment. Scand J Infect Dis 1988 0.75
202 Successful acyclovir and the successors. Med Biol 1983 0.75
203 [Influenza vaccinations--use with care]. Duodecim 1997 0.75
204 Temperature-dependent and transformation-associated changes in polyamine metabolism in normal and Rous sarcoma virus-infected chick embryo fibroblasts. Biochim Biophys Acta 1981 0.75
205 [Water-borne outbreak of serous meningitis caused by Echovirus-30 in Belarus]. Zh Mikrobiol Epidemiol Immunobiol 2001 0.75
206 Oral poliovirus vaccination and pregnancy complications. Acta Obstet Gynecol Scand 1995 0.75
207 Unintended plasma exchange therapy in poliomyelitis: difficulties in the differential diagnosis of paralytic poliomyelitis and polyradiculitis. Ann Clin Res 1987 0.75
208 [Can the Finnish immunization program be improved?]. Duodecim 1992 0.75
209 [Paralytic poliomyelitis epidemic in Finland 1984-85]. Duodecim 1985 0.75
210 Herpes simplex virus as an inducer of interferon in human monocyte cultures. Antiviral Res 1987 0.75
211 Defective defences. Med Biol 1978 0.75